DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
12 juil. 2024 10h15 HE
|
Faruqi & Faruqi LLP
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Biogen To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Biogen...
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
09 juil. 2024 09h00 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, July 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Biogen Inc....
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
04 juil. 2024 10h20 HE
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 in Biogen between February 3, 2022 and February 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
28 juin 2024 09h40 HE
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 in Biogen between February 3, 2022 and February 13, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at...
Biogen Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
03 juin 2024 15h38 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, June 03, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Biogen Inc. (“Biogen”)...
Digital Biomarkers Market Poised for Exponential Growth to reach US$ 31.2 billion by 2032 as Cutting-Edge Technology Takes Center Stage - By PMI
23 févr. 2023 09h07 HE
|
PMI
Covina, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Digital biomarkers are driven by the growing need for smartphone-compatible and wireless medical equipment, as well as technological advancements in...